215: The Clinical Utility of eGFR Slope as a Surrogate Endpoint in Lupus Nephritis and ESKD

Monday, October 31, 2022

10:00 AM – 10:05 AM Eastern Time

All of the relevant financial relationships listed for faculty have been mitigated.

Industry Presenter(s)

JR

Jai Radhakrishnan, MD

Professor of Medicine
Columbia University
New York, New York, United States

Disclosure information not submitted.

This session will discuss how clinicians can leverage eGFR slope to assess for kidney disease progression and risk for ESKD in patients with lupus nephritis.

Developed and offered by GSK